The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis? by Kostas A. Papavassiliou, Athanasios G. Papavassiliou

Get full text

Stabilizing the integrity of intestinal barrier to control arthritis by George D. Kalliolias, Athanasios G. Papavassiliou

Get full text

Targeting hypoxia inducible factor-1 alpha in rheumatoid arthritis: Rationale, opportunities and challenges by George D. Kalliolias, Athanasios G. Papavassiliou

Get full text

Integrating Signaling Pathways with Transcription Factor Networks—On the Trail of Sisyphus? by Kostas A. Papavassiliou, Athanasios G. Papavassiliou

Get full text

Epigenetic mechanisms regulating COVID-19 infection by Sarantis Chlamydas, Athanasios G. Papavassiliou, Christina Piperi

Get full text

Complexity in cancer biology: is systems biology the answer? by Evangelia Koutsogiannouli, Athanasios G. Papavassiliou, Nikolaos A. Papanikolaou

Get full text

CA-125:CA72-4 ratio − towards a promising cost-effective tool in ovarian cancer diagnosis and monitoring of post-menopausal women under hormone treatment by Angeliki Margoni, Antonios N. Gargalionis, Athanasios G. Papavassiliou

Get full text

Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC) by Kostas A. Papavassiliou, Georgios Marinos, Athanasios G. Papavassiliou

Get full text

Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives by Kostas A. Papavassiliou, Nektarios Anagnostopoulos, Athanasios G. Papavassiliou

Get full text

Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment by Christina Piperi, Kostas A. Papavassiliou, Athanasios G. Papavassiliou

Get full text

Targeting STAT3 Signaling Pathway in Colorectal Cancer by Antonios N. Gargalionis, Kostas A. Papavassiliou, Athanasios G. Papavassiliou

Get full text

Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives by Antonios N. Gargalionis, Kostas A. Papavassiliou, Athanasios G. Papavassiliou

Get full text

The Molecular Basis of Retinoids’ Use in Breast Cancer Chemoprevention by Michalis V. Karamouzis, Panagiotis A. Konstantinopoulos, Athanasios G. Papavassiliou

Get full text

Direct YAP/TAZ–TEAD inhibitor paves the way toward realizing cancer mechanomedicine by Kostas A. Papavassiliou, Antonios N. Gargalionis, Athanasios G. Papavassiliou

Get full text

Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update by George D. Kalliolias, Efthimia K. Basdra, Athanasios G. Papavassiliou

Get full text

The potential of tumour mechanotargeting in lung cancer therapeutics by Kostas A. Papavassiliou, Antonios N. Gargalionis, Athanasios G. Papavassiliou

Get full text

Biomarkers in Cerebrospinal Fluid for the Diagnosis and Monitoring of Gliomas by Dimosthenis Papadimitrakis, Miltiadis Perdikakis, Antonios N. Gargalionis, Athanasios G. Papavassiliou

Get full text

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors by Evangelos Koustas, Panagiotis Sarantis, Athanasios G. Papavassiliou, Michalis V. Karamouzis

Get full text

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights by Aristomenis Anestis, Ilianna Zoi, Athanasios G. Papavassiliou, Michalis V. Karamouzis

Get full text

Leveraging the ROS–TME Axis for Cancer Treatment by Kostas A. Papavassiliou, Amalia A. Sofianidi, Vassiliki A. Gogou, Athanasios G. Papavassiliou

Get full text